Innospec earnings were $121.5M for the trailing 12 months ending Jun 30, 2026, with 537.7% growth year over year. The latest IOSP earnings report on Jun 30, 2026 announced Q2 2026 earnings of $30.8M, up 1.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IOSP reported annual earnings of $116.6M, with 227.5% growth.
IOSP past earnings growth
How has IOSP's earnings growth performed historically?
On IOSP's earnings call on Aug 4, 2026, Innospec (NASDAQ: IOSP) reported Q2 2026 earnings per share (EPS) of $1.25, up 32.98% year over year. Total IOSP earnings for the quarter were $30.80 million. In the same quarter last year, Innospec's earnings per share (EPS) was $0.94.
As of the last Innospec earnings report, Innospec is currently profitable. Innospec's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $121.50 million, a 529.53% increase year over year.
What was IOSP's earnings growth in the past year?
As of Innospec's earnings date in Aug 4, 2026, Innospec's earnings has grown 537.66% year over year. This is 531.22 percentage points higher than the US Specialty Chemicals industry earnings growth rate of 6.44%. IOSP earnings in the past year totalled $121.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.